Bond, Aaron (Juli 2006). "Exenatide (Byetta) as a novel treatment option for type 2 diabetes mellitus". Baylor University Medical Center Proceedings 19 (3): 281–4. PMID17252050.
Maruno K, Said SI (1993). "Small-cell lung carcinoma: inhibition of proliferation by vasoactive intestinal peptide and helodermin and enhancement of inhibition by anti-bombesin antibody". Life Sci. 52 (24): PL267–71. doi:10.1016/0024-3205(93)90640-O. PMID8389407.
